NFKB1 and glioma: Alizadeh et al. (2018) could demonstrate that SWCNTs functionalized with the antigen, CpG, selectively inhibited the migration of glioma cells and decreased their NF‐κB activation, while activating the immune system, particularly macrophages, by induction of the TLR9/NF‐κB pathway.